Cart
sales@molnova.com
CRANAD 2
CAS No. 1193447-34-5
CRANAD 2( —— )
Catalog No. M23364 CAS No. 1193447-34-5
CRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 30 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 265 | In Stock |
|
| 100MG | 388 | In Stock |
|
| 200MG | 551 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCRANAD 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits.
-
DescriptionCRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits. Upon interacting with Abeta aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1193447-34-5
-
Formula Weight410.26
-
Molecular FormulaC23H25BF2N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCN(C)C1=CC=C(/C=C/C2=[O+][B-](F)(F)OC(/C=C/C3=CC=C(N(C)C)C=C3)=C2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jara-Guajardo P , Cabrera P , Celis F , et al. Gold Nanoparticles Mediate Improved Detection of β-amyloid Aggregates by Fluorescence[J]. Nanomaterials, 2020, 10(4).
molnova catalog
related products
-
Rubiadin
Rubiadin possesses potent antioxidant property, it can prevent lipid peroxidation induced by FeSO4 and t-butylhydroperoxide (t-BHP) in a dose dependent manner.
-
J-14
J-14 is an inhibitor of reversible sulfiredoxin(IC50 : 8.1 μM).?J14 induces oxidative stress (intracellular ROS accumulation) by inhibiting sulfiredoxin leading to cytotoxicity and cancer cell death.
-
PA-8
PA-8 is a small molecule receptor antagonist for PACAP Type I (PAC1) that is selective, effective, and orally active. PA-8 inhibits PacAP-induced CREB phosphorylation at PAC1- receptors, but does not inhibit VPAC1- or vpac2 receptors.
